Concepedia

Elektra J. Papadopoulos

EJ

Statistics

Publications

16

Citations

794

H-Index

14

Active since

1997

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Critical Path Institute

The University of Texas MD Anderson Cancer Center

Janssen (United States)

Elektra J. Papadopoulos is an author at United States Food and Drug Administration specializing in medicine, outcomes research, and oncology.

Top concepts

Publications per year

1997–2023

16

Publications

16

Guillain‐Barré and Miller Fisher syndromes occurring with tumor necrosis factor α antagonist therapy

In‐Sook J. Shin, Alan N. Baer, Hyon‐Jo Kwon et al. · Arthritis & Rheumatism · 2006 · 193 citations

Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation

Elektra J. Papadopoulos, Chris Sassetti, Hidehisa Saeki et al. · European Journal of Immunology · 1999 · 168 citations · Full text

Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane‐bound chemokine expressed constitutively in diverse cells of the skin

Elektra J. Papadopoulos, David J. Fitzhugh, Christine Tkaczyk et al. · European Journal of Immunology · 2000 · 89 citations

, , +21

U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma

Harpreet Singh, Michael H. Brave, Julia A. Beaver et al. · Clinical Cancer Research · 2016 · 51 citations

, , +15

Developing and Implementing Performance Outcome Assessments: Evidentiary, Methodologic, and Operational Considerations

Elizabeth A. Richardson, Jessica Burnell, Heather Adams et al. · Therapeutic Innovation & Regulatory Science · 2018 · 47 citations

, , +10

1–5 of 16